SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | 476.29 |
Enterprise Value ($M) | 205.32 |
Book Value ($M) | 262.19 |
Book Value / Share | 3.58 |
Price / Book | 1.82 |
NCAV ($M) | 241.78 |
NCAV / Share | 3.30 |
Price / NCAV | 1.97 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.34 |
Return on Assets (ROA) | -0.79 |
Return on Equity (ROE) | -1.25 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 9.00 |
Current Ratio | 9.00 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 299.36 |
Assets | 319.77 |
Liabilities | 57.58 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Commodore Capital Lp | 9.90 | 40.17 | |
13G | BlackRock, Inc. | 7.00 | 0.00 | |
13G | Deep Track Capital, LP | 9.49 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
219,457 | 794,861 | 27.61 | |
276,778 | 1,094,174 | 25.30 | |
386,338 | 1,708,404 | 22.61 | |
(click for more detail) |
Similar Companies | |
---|---|
MGTX – MeiraGTx Holdings plc | MIST – Milestone Pharmaceuticals Inc. |
MLYS – Mineralys Therapeutics, Inc. | MRNA – Moderna, Inc. |
MRSN – Mersana Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io